InvestSMART

Cyclopharm Limited (ASX:CYC)

ALERT: Price-sensitive ASX Announcement for CYC
Current share price for CYC : $0.465 -0.02 (-4.12%)+
Announcement
Release
15 Jul 2026 8:29AM
Price at Release
$0.485
Full Release
download
Summary
Cyclopharm Limited has announced a significant agreement with University Hospitals in Cleveland, Ohio, for the immediate installation of their Technegas technology across 11 sites. This deployment, which is immediate rather than staged, reflects the growing trust in Technegas for its clinical utility in diagnosing pulmonary embolism and potentially other respiratory conditions. The agreement establishes a major presence for Cyclopharm in the northern Ohio region and is seen as a crucial step in their U.S. growth strategy. Each installation will contribute to recurring revenue from functional lung ventilation imaging procedures, with University Hospitals serving as a reference site to encourage further adoption across the U.S. Midwest.
Key Points
  • Landmark agreement with University Hospitals, Cleveland for Technegas installations
  • Immediate deployment across 11 locations
  • Strengthens Cyclopharm's presence in the U.S. Midwest
  • Technegas used for diagnosing pulmonary embolism and other conditions
  • University Hospitals to serve as a reference site for further U.S. adoption
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.